ALIOS BIOPHARMA INC — Form D/A
ALIOS BIOPHARMA INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2009-06-19. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-06-19
- Form: D/A
- Accession: 0001380990-09-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $11.0M
- Amount sold: $11.0M
- Investors: 18
- Date of first sale: 2008-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-96479
Issuer
- Name: ALIOS BIOPHARMA INC
- CIK: 0001380990
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 260 EAST GRAND AVENUE, 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (650) 635-5500
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| John Donovan | Executive Officer | Houston, TX |
| Peter Hirth | Director | South San Francisco, CA |
| Leonid Beigelman | Executive Officer | South San Francisco, CA |
| Lawrence Blatt | Director | South San Francisco, CA |
| Lawrence Blatt | Executive Officer | South San Francisco, CA |
| Jack Nielsen | Director | Palo Alto, CA |
| Jens Eckstein | Director | Cambridge, MA |
| Campbell Murray | Director | NOVATO, CA |
| Kent Gossett | Director | Conshocken, PA |
Other filings by this issuer (2)
More